The search found 309 results in 0.183 seconds.
In a cost-controlled health-care environment, only those technologies capable of providing a major enhancement to the quality of life and a reduction in cost will be driven forward.
"Germany has a strong midfield in the biotech sector, but compared with the United States or the United Kingdom, we are lacking top companies. --Dr. Julia Schüler, Ernst & Young"
E-mail your questions for Dr. Clemmons email@example.com
"You can't turn the money on and just watch it regenerate itself," says Michael Pivovaroff.
Science Careers looks at the pros and cons for young scientists to take part in interactive peer review processes both as authors and reviewers.
Peter Fiske redefines the concept of "entrepreneurship" to encompass all the ways you can make a difference in your work and your life.
Regulations at every step of drug development mean jobs for regulatory scientists at every step, too.
There is still a gap between modeling-based predictions and deciding when to evacuate a city.
© 2014 American Association for the Advancement of Science. All Rights Reserved.
AAAS is a partner of HINARI, AGORA, OARE, PatientInform, CrossRef, and COUNTER.
You have reached the bottom of the page. Back to top